Managed Healthcare Executive1d
FDA Approves Combination Antibiotic for Complicated Infections
Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
pharmaphorum4d
Merck gets FDA nod for new antibiotic, but says use with care
The FDA has approved a new triple-drug antibiotic from Merck & Co, but the company and regulator have cautioned it should only be prescribed for last-ditch use. Recarbrio – which based on ...
pharmaphorum1y
Innoviva gets FDA nod for pneumonia antibiotic
The FDA has given a green light to Innoviva’s antibiotic combination Xacduro, which becomes the first drug specifically approved for ... s pilot of a subscription-based payment system ...
Healio5d
FDA approves Emblaveo for complicated intra-abdominal infections
Emblaveo is the first monobactam/beta-lactamase inhibitor and antibiotic combination approved for this condition. The approval was based on results from the phase 3 REVISIT trial. The FDA has ...